C19H20N4O
320.4 g/mol
APIDanger
Niraparib
CAS1038915-60-4EC685-112-3
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Niraparib is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is a PARP inhibitor compound investigated for applications in oncology.
PARP inhibitor researchoncology research compound
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1038915-60-4
Related Compounds
StrongSame Parent
Niraparib tosylate monohydrate
CAS1613220-15-7
pharmaceutical raw material
ReferenceSame Category
9-dehydromethyltestosterone
CAS1039-17-4
pharmaceutical raw material
ReferenceSame Category
Maxacalcitol
CAS103909-75-7
pharmaceutical raw material
ReferenceSame Category
Α-methylthiofentanyl
CAS103963-66-2
pharmaceutical raw material
ReferenceSame Category
Ceftiofur hydrochloride
CAS103980-44-5
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H340May cause genetic defects
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide
InChIKey
PCHKPVIQAHNQLW-CQSZACIVSA-N
SMILES
C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N
Synonyms (18)
- 3JD
- Niraparib (USAN)
- MK 4827 (Base)
- MK-4827 (Niraparib)
- MK-4827 (PARP-1)
- Niraparib
- Niraparib (Standard)
- Niraparib(MK4827) free base?
- compound 56
- niraparibum